Clinical Trial

Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study

Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, single arm, non-randomized early feasibility study to evaluate the preliminary safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective above-knee femoral popliteal bypass surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-22.
Trial Details
NCT Number NCT06951685
Lead Sponsor Xeltis
Conditions Peripheral Artery Occlusive Disease
Enrollment 6 participants
Start Date 2025-05-02
Primary Completion 2026-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-07-15